Serina Share Price
AMEX: SER | Micro Cap | HealthcareSerina Stock Performance
Serina Share Price Chart
Serina Quarterly Profit & Loss
All figures in USD
Serina Annual Profit & Loss
All figures in USD
Serina Balance Sheet
All figures in USD Million
Serina Cash Flow
All figures in USD Million
About Serina
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Serina Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.98 | $1.26 | -30.77% |
Oct 2026 | $2.00 | $1.82 | -10.57% |
Sep 2026 | $2.43 | $2.04 | -21.12% |
Aug 2026 | $2.04 | $2.58 | +23.44% |
Jul 2026 | $1.92 | $2.09 | +7.73% |
Jun 2026 | $1.82 | $1.94 | +4.30% |
May 2026 | $1.82 | $1.86 | +2.20% |
Apr 2026 | $2.00 | $1.82 | -6.19% |
Mar 2026 | $1.70 | $1.94 | +8.38% |
Feb 2026 | $2.98 | $1.79 | -41.69% |
Jan 2026 | $2.06 | $3.07 | +65.05% |
Dec 2025 | $3.70 | $1.86 | -56.03% |